ingle-cell and single-nucleus RNA sequencing (scRNA-seq and snRNA-seq) have emerged as powerful technologies for interrogating the heterogeneous transcriptional profiles of multicellular systems. Early scRNA-seq workflows were limited to analyzing tens to hundreds of single-cell transcriptomes at a time 1, 2 . With the advent of single-cell sequencing technologies based on microwells 3 , combinatorial indexing 4, 5 and droplet-microfluidics [6] [7] [8] [9] , the parallel transcriptional analysis of 10 3 -10 5 cells or nuclei is now routine. This increase in cell throughput has catalyzed efforts to characterize the composition of whole organs 10 and entire organisms 4, 11 . These technologies will increasingly be used to reveal the mechanisms by which cell populations interact to promote development, homeostasis and disease. This shift from descriptive to mechanistic analyses requires integrating spatiotemporal information, diverse perturbations and experimental replicates to draw strong conclusions 12, 13 . While existing methods can assay many thousands of cells, sample-specific barcodes (for example, Illumina library indices) are incorporated at the very end of standard library preparation workflows. This practice necessitates the parallel processing of individual samples, which limits scRNA-seq sample-throughput due to reagent costs and the physical constraints of droplet-microfluidics devices. Sample multiplexing approaches address this limitation by labeling cells with sample-specific barcodes before pooling and single-cell isolation. Much as transcripts are linked to cell barcodes during reverse transcription, these techniques assign cells into sample groups by tracking which cells share sample-specific barcodes. Several multiplexing methods have been described that distinguish samples using pre-existing genetic diversity 14 , or introduce sample barcodes using either genetic [15] [16] [17] [18] [19][20] or non-genetic 21-23 mechanisms.
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However, each of these methods has liabilities, including issues with scalability, universality and the potential to introduce secondary perturbations to experiments. We identified lipid-and cholesterol-modified oligonucleotides (LMOs and CMOs) as reagents that circumvent many of the limitations of other sample multiplexing techniques. We previously described LMO and CMO scaffolds that rapidly and stably incorporate into the plasma membrane of live cells by step-wise assembly 24 . Here, we adapt LMOs and CMOs into MULTI-seq: scRNA-seq and snRNA-seq sample multiplexing using lipid-tagged indices. MULTI-seq localizes sample barcodes to live cells and nuclei regardless of species or genetic background while preserving cell viability and endogenous gene expression patterns.
Results
MULTI-seq overview. MULTI-seq localizes DNA barcodes to plasma membranes by hybridization to an 'anchor' LMO. The 'anchor' LMO associates with membranes through a hydrophobic 5′ lignoceric acid amide. Subsequent hybridization to a 'co-anchor' LMO incorporating a 3′ palmitic acid amide increases the hydrophobicity of the complex and thereby prolongs membrane retention (Fig. 1a) . MULTI-seq sample barcodes include a 3′ poly-A capture sequence, an 8-bp sample barcode and a 5′ PCR handle necessary for library preparation and anchor hybridization. Cells or nuclei carry membrane-associated MULTI-seq barcodes into emulsion droplets where the 3′ poly-A domain mimics endogenous transcripts during hybridization to messenger RNA capture beads. Endogenous transcripts and MULTI-seq barcodes are then linked to a common cellor nucleus-specific barcode during reverse transcription, which enables sample demultiplexing. MULTI-seq barcode and endogenous expression libraries are separated by size selection before nextgeneration sequencing (NGS) library construction, enabling pooled sequencing at user-defined proportions (Methods). The same strategy can be applied to commercially available CMOs.
We used flow cytometry to evaluate whether LMOs and CMOs predictably label and minimally exchange between live cells at typical sample preparation temperatures of 4 °C ( Supplementary Fig. 1a,b) . Identical experiments were also performed using freshly isolated nuclei ( Supplementary Fig. 1c,d ). These data revealed that LMOs exhibit longer membrane residency times than CMOs on live-cell membranes at 4 °C, whereas LMOs and CMOs exchange comparably between live cells at room temperature, suggesting cells should be maintained on ice to achieve optimal sample multiplexing results ( Supplementary Fig. 1e ). For nuclei, both oligonucleotide conjugates showed minimal exchange between nuclear membranes ( Supplementary Fig. 1d) ; however, bovine serum albumin (BSA) in nuclei isolation buffer specifically quenched LMOs, reducing labeling . n = 1,950 MULTI-seq barcoded HMECs. Data are represented as mean ± s.e.m. f, Single-nucleus MULTI-seq sample classification proportions for each cell type identified by clustering in gene expression space (see Supplementary Fig. 2e-g ). n = 5,894 MULTI-seq barcoded nuclei. g, MULTI-seq sample classifications in Jurkat cells following activation with ionomycin and PMA for varying amounts of time. Time-point centroids in gene expression space are denoted with larger circles. n = 3,709 Jurkat nuclei. h, Violin plots of gene expression marking different stages of Jurkat cell activation. n = 3,709 Jurkat nuclei.
efficiency ( Supplementary Fig. 1b) . While problematic during nuclei labeling, we reasoned that LMO quenching could be strategically employed during live-cell labeling to reduce off-target barcoding and potentially minimize washes before sample pooling. We found that diluting LMO-labeling reactions with 1% BSA in PBS resulted in minimal off-target labeling following pooling (<1% of primary labeling signal), which was 18-fold lower than dilution with PBS ( Supplementary Fig. 1f ).
MULTI-seq enables scRNA-seq sample demultiplexing. We tested the capacity of MULTI-seq to demultiplex scRNA-seq samples by performing a proof-of-concept experiment using human embryonic kidney (HEK) 293 cells (HEK293) and primary human mammary epithelial cells (HMECs) cultured in the presence or absence of transforming growth factor (TGF)-β (Fig. 1b) . Cells were trypsinized, barcoded with LMOs or CMOs and pooled before droplet microfluidic-emulsion with the 10x Genomics Chromium system. In parallel, we prepared unbarcoded replicates to test whether MULTIseq influenced gene expression or mRNA capture efficiency.
Following data pre-processing (Methods), we analyzed a final scRNA-seq dataset containing 14,377 total cells. We identified clusters in gene expression space according to known markers for HEKs as well as the two cellular components of HMECs, myoepithelial (MEPs) and luminal epithelial cells (LEPs; Fig. 1c and Supplementary Fig. 2a ). Projecting MULTI-seq barcode classifications onto gene expression space for LMO-labeled ( Fig. 1d ) and CMO-labeled cells ( Supplementary Fig. 2b ) illustrates that both membrane scaffolds successfully demultiplexed each sample. HMECs predicted to have been cultured with TGF-β exhibited enriched TGF-β induced (TGFBI) gene expression (Fig. 1e) . Moreover, RNA and MULTI-seq barcode unique molecular identifier (UMI) counts were not negatively correlated, demonstrating that MULTI-seq does not impair mRNA capture ( Supplementary  Fig. 2c ). However, we observed transcriptional changes in CMOlabeled HEKs ( Supplementary Fig. 2d and Supplementary Table 1) that were absent in LMO-labeled HEKs.
Demultiplexing snRNA-seq and time-course experiments. snRNA-seq is widely used for analyses of solid tissues that are difficult to dissociate 25 . We explored whether MULTI-seq could demultiplex snRNA-seq samples by purifying nuclei from HEKs and mouse embryonic fibroblasts (MEFs) and labeling each pool of nuclei with LMOs or CMOs before snRNA-seq. In parallel, we multiplexed Jurkat cells treated with ionomycin and phorbol 12-myristate 13-acetate (PMA) at eight time-points (0-24 h) to track T-cell activation dynamics (Supplementary Fig. 2e ). MULTI-seq sample classifications matched their intended cell-type clusters in gene expression space ( Supplementary Fig. 2f,g ) with an ~0.5% misclassification rate (Fig. 1f) . MULTI-seq classifications were species-specific and predicted ~85% of mouse-human doublets, which approximates the theoretical doublet detection limit for MULTI-seq experiments with 12 samples of 91.7%. Matching live-cell results, MULTI-seq barcoding did not impair mRNA capture (Supplementary Fig. 2h ). In contrast to live-cell results, both CMO-and LMO-labeled nuclei were transcriptionally indistinguishable from unbarcoded controls ( Supplementary Fig. 2i ). Moreover, CMO-labeled nuclei had higher average signal-to-noise ratio (SNR) and total number of barcode UMIs relative to LMO-labeled nuclei (Supplementary Table 2 ), consistent with previous flow cytometry results.
On demultiplexing individual time-points along the trajectory of T-cell activation (Fig. 1g) , we observed multiple literaturesupported transcriptional dynamics (Fig. 1h) Supplementary Fig. 3a) . We barcoded each sample before pooling and loaded cells across three 10× microfluidics lanes, resulting in a 32-fold reduction in reagent use relative to standard practices.
To classify HMECs into sample groups, we implemented a sample classification workflow inspired by previous strategies 15, 16, 21 (Methods, Supplementary Materials and Supplementary Fig. 4 ) that identified 76 sample groups consisting of 26,439 total cells ( Supplementary Fig. 3b ). Each group was exclusively enriched for a single barcode (Fig. 2a , left, and Supplementary Fig. 3c ) an average of ~199-fold above the most abundant off-target barcode ( Supplementary Fig. 3d ). Unlike sample multiplexing data with relatively few samples, MULTI-seq-defined doublets localized to the peripheries of singlet clusters in barcode space for this experiment (Fig. 2a, right) . We suspected that missing barcodes resulted from handling errors during sample preparation (Supplementary Fig. 3b and Supplementary Materials), as a technical replicate yielded all 96 sample groups ( Supplementary Fig. 3e-g ).
To assess demultiplexing accuracy, we grouped MULTI-seq classifications according to cell-type composition (for example, MEPs alone, LEPs alone or both) and visualized these groups in gene expression space. Unsupervised clustering and marker analysis of the resulting transcriptome data distinguished LEPs from MEPs along with a subset of ambiguous cells expressing markers for both cell types (Fig. 2b , left, and Supplementary Fig. 5a ). MULTI-seq classifications matched their expected cell-type clusters (Fig. 2b, right) , while cells co-expressing MEP and LEP markers were predominantly defined as doublets. MULTI-seq identified doublets that were overlooked when predicting doublets using marker genes (Fig. 2b, arrow) . Additionally, MULTI-seq doublet classifications generally agreed with computational predictions generated using DoubletFinder 32 (Fig. 2c , sensitivity, 0.283 and specificity, 0.965), with the exception of 'homotypic' doublets-that is, doublets formed from transcriptionally similar cells-to which computational doublet detection techniques are insensitive 32, 33 (Supplementary Materials). Moreover, DoubletFinder erroneously classified proliferative LEPs as doublets (Fig. 2c, arrow) , illustrating how computational doublet inference performance suffers when applied to datasets with low cell-type numbers 32, 33 .
MULTI-seq identifies transcriptional responses to co-culture conditions and signaling molecules. Sample demultiplexing, doublet removal and quality-control filtering resulted in a final scRNAseq dataset including 21,753 total cells, revealing two transcriptional responses linked to culture composition. First, we observed that LEPs co-cultured with MEPs exhibited enriched proliferation relative to LEPs cultured alone ( Fig. 2d and Supplementary Fig. 5b ). In contrast, MEPs were equally proliferative when cultured alone or with LEPs ( Supplementary Fig. 5c ). Second, we observed that nonproliferative co-cultured MEPs and LEPs were enriched for TGFBI expression relative to MEPs and LEPs cultured alone (Fig. 2d , bottom right, and Supplementary Fig. 5d ).
We next used hierarchical clustering to assess how LEPs or MEPs responded to signaling molecule exposure. HMECs exposed to the EGFR ligands AREG and EGF exhibited gene expression profiles that were notably different from control cells. AREG-and EGFstimulated LEPs expressed increased levels of EGFR signaling genes (for example, DUSP4, ref.
34
) and genes up-regulated in HER2 + breast cancers (for example, PHLDA1 (ref.
35
) and Fig. 2e ) relative to control LEPs. AREG-and EGF-stimulated MEPs also express high levels of known EGFR-regulated genes (for example, ANGPTL4 (ref.
36
) and Supplementary Fig. 5e ).
MULTI-seq identifies low-RNA cells in cryopreserved, primary patient-derived xenograft (PDX) samples.
Using scRNA-seq to analyze archival primary tissue samples is often difficult because these samples can have low cell viability that is compounded during cryopreservation, thawing, enzymatic digestion and scRNA-seq sample preparation. We investigated whether the rapid and nonperturbative nature of MULTI-seq barcoding would enable cryopreserved tissue multiplexing using samples dissected from a PDX mouse model of metastatic triple-negative breast cancer 37 . In this model system, the diameter of primary tumors was used as a proxy for metastatic progression in the lung ( Supplementary Fig. 6a ). We barcoded nine distinct samples representing primary tumors and lungs from early-and mid-stage PDX mice (in duplicate), one late-stage PDX mouse and a single lung from an immunodeficient mouse without tumors (Fig. 3a) . We then pooled fluorescenceactivated cell sorting (FACS)-enriched populations of barcoded hCD298 + human metastases with mCD45 + mouse immune cells before 'super-loading' a single 10x Genomics microfluidics lane.
Quality-control filtering, sample classification and doublet removal resulted in a final scRNA-seq dataset of 9,110 mouse and human singlets spanning all nine samples ( Fig. 3b and Supplementary Fig. 6b ). Under the conditions tested, barcode SNR was largely invariant to inter-sample differences in total cell number and viability (Supplementary Fig. 6c and Supplementary Table 3) . Classification accuracy was supported by tissue-specific gene expression patterns ( Supplementary Fig. 6d ) and comparisons to FACS enrichment results ( Supplementary Fig. 6e ). Additionally, MULTI-seq classifications identified high-quality single-cell transcriptomes that would have been discarded using standard qualitycontrol workflows (for example, Cell Ranger RNA UMI inflection point threshold equal to 1,350, Fig. 3c + and plasmocytoid DCs) and endothelial cells 10, 40 (Fig. 3d , top, and Supplementary Fig. 6f ). The use of immunodeficient PDX mice resulted in a lack of lymphocytes (for example, T, B and NK cells).
We observed literature-supported changes in immune cell proportions ( Fig. 3d ) and transcriptional state (Fig. 3e) at each tumor stage. For instance, neutrophils were enriched in early-stage PDX mice while alveolar macrophages were depleted over the course of metastasis 41, 42 . Moreover, stage-specific transcriptional heterogeneity among classical monocytes (Fig. 3f) Fig. 6g ), enabling the identification of genes up-regulated in classical monocytes during metastatic progression (Supplementary Table 5 ). Clustering also revealed that classical monocytes from late-stage PDX mice fell into two distinct transcriptional states discernible by Cd14 expression (Fig. 3f , inset, and Supplementary Table 6) matching previous observations 44 . Genes that are differentially expressed between classical monocyte subsets include genes known to influence metastatic progression 43, 45, 46 (for example, Thbs1, S100a8, S100a9 and Wfdc21). To rule out the possibility that these results were primarily due to inter-mouse variability, we used Earth Mover's Distance (EMD) 47 to quantify the magnitude of transcriptional dissimilarity between lung classical monocytes from each mouse and tumor stage. These results illustrate that classical monocytes from earlyand mid-stage mouse replicates (scaled EMD = 0.16) were more similar than classical monocytes from distinct tumor stages (scaled EMD = 0.69).
Discussion
MULTI-seq is a scalable multiplexing approach because it uses inexpensive reagents, involves minimal sample handling and is rapid and modular in design. MULTI-seq modularity enables any number of samples to be multiplexed with a single pair of 'anchor' and 'co-anchor' LMOs. Moreover, since LMOs are quenchable with BSA and can be incorporated during proteolytic dissociation, we anticipate that further method optimization will facilitate wash-free sample preparation workflows. When integrated with automated liquid handling, these features position MULTI-seq as a powerful technology enabling 'screen-by-sequencing' applications (for example, L1000 (ref.
48
) and DRUG-seq 49 ) in multicellular systems (for example, organoids, PBMCs and so on).
In this study, we leveraged MULTI-seq scalability to perform a 96-plex HMEC perturbation assay, revealing noteworthy principles for future scRNA-seq sample multiplexing experiments. Specifically, we observed that responses to signaling molecules were less pronounced than responses linked to cellular composition. For instance, co-cultured MEPs and LEPs engage in TGF-β signaling that is absent in the associated monocultures. In contrast, MEPs and LEPs only exhibited pronounced transcriptional responses to the EGFR ligands AREG and EGF in these data, despite the established roles of all tested signaling molecules in mammary morphogenesis. We speculate that rich media formulations used to expand cells, such as the M87A media (-EGF) used here, likely buffer cells against microenvironmental perturbations. Thus, careful consideration of cell-type composition and media formulation will be essential to accurately interpret future scRNA-seq experiments.
Beyond its scalability, MULTI-seq improves scRNA-seq data quality in two distinct ways. First, MULTI-seq identifies doublets as cells associated with multiple sample indices. The ability to detect doublets allows for droplet-microfluidics devices to be 'super-loaded' , resulting in roughly five-fold improvement in cellular throughput 14, 21 . Moreover, unlike computational doublet prediction methods 32, 33 , MULTI-seq detects homotypic doublets and performs well on scRNA-seq data with minimal cell-type complexity. However, since computational doublet detection methods detect doublets formed from cells with shared sample barcodes 32 , doublet detection should ideally involve a synergy of computational and molecular approaches.
Second, MULTI-seq improves scRNA-seq data quality by 'rescuing' cells that would otherwise be discarded by quality-control workflows using RNA UMI thresholds. Such workflows are systematically biased against cell types with low RNA content 39 . MULTIseq classifications provide an orthogonal metric to RNA UMIs for distinguishing low-RNA from low-quality cells. We leveraged this feature (described initially by Stoeckius et al. 21 ) to improve the quality of the PDX dataset, where MULTI-seq classifications 'rescued' >90% of the sequenced neutrophils while avoiding misclassification of broken cells.
Finally, MULTI-seq is universally applicable to any sample including cells or nuclei with an accessible plasma membrane. As a result, we used the same set of MULTI-seq reagents to multiplex 15 distinct cell types or nuclei from both mice and humans. CMOs outperformed LMOs in nuclei isolation buffers containing BSA because BSA sequesters LMOs. Further, we anticipate that MULTIseq is compatible with sample preservation strategies such as flashfreezing and fixation.
We leveraged all three of these features-scalability, universality and data quality improvement-to multiplex cryopreserved primary tumors and lungs dissected from PDX mouse models at varying stages of metastatic progression. PDX sample multiplexing requires barcoding cells from (1) multiple species that may (2) down-regulate surface epitopes commonly targeted by antibodybased multiplexing techniques (for example, MHC-1, ref.
50
) and (3) have intrinsically low viability requiring minimal sample handling. MULTI-seq successfully demultiplexed every sample, revealing several immune cell responses to metastatic progression in the lung. For example, we confirmed previous reports of metastasis-associated shifts in neutrophil, alveolar macrophage and classical monocyte proportions. These findings indicate that MULTI-seq can identify known aspects of disease progression. However, we also observed several changes in the immune microenvironment that to our knowledge have not been previously reported, including significant shifts in interstitial macrophages, dendritic cells and non-classical monocytes. Although these findings will require further experimentation for validation, they indicate that MULTI-seq may provide new insights into disease progression that would be less accessible without sample multiplexing.
Moreover, we identified classical monocyte subsets that were discernible by Cd14 expression and genes with diverse effects on metastatic progression. Cd14-high classical monocytes expressing the pro-metastatic gene Thbs1 (ref.
45
) and Cd14-low classical monocytes expressing the anti-metastatic genes S100a8, S100a9 and Wfdc21 (ref. 46 ) coexisted in metastasized lungs. Since we isolated immune cells from the whole lung in this study, we could not discern whether Cd14-high and Cd14-low states were spatially correlated with metastatic sites. However, MULTI-seq could be employed to spatially barcode distinct regions of a single metastatic lung, enabling direct interrogation of classical monocyte spatial heterogeneity.
In summary, MULTI-seq broadly enables users to incorporate additional layers of information into scRNA-seq experiments. We anticipate that in the future, more diverse types of information will be targeted, including spatial coordinates, time-points, species-oforigin and sub-cellular structures (for example, nuclei from multinucleated cells). We also anticipate that increasing LMO membrane residency time using alternative oligonucleotide conjugate designs may enable MULTI-seq applications for non-genetic lineage tracing and/or cellular competition assays.
online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of code and data availability and associated accession codes are available at https://doi.org/10.1038/ s41592-019-0433-8. l-glutamine, 3.7 g l −1 NaHCO 3 , supplemented with 10% fetal bovine serum (FBS) and penicillin/streptomycin (100 U ml -1 and 100 μg ml . This gating strategy results in trace numbers of MEPs and LEPs sorted incorrectly. HMEC sub-populations were sorted into 24-well plates such that wells contained LEPs only, MEPs only or a 2:1 ratio of LEPs to MEPs. Sorted cell populations were cultured for 48 h in M87A media before culturing for 72 h in M87A media (-EGF) supplemented with different signaling molecules or signaling molecule combinations. Specifically, M87A media (-EGF) was supplemented with 100 ng ml −1 RANKL, 100 ng ml
WNT4, 100 ng ml −1 IGF-1, 113 ng ml −1 AREG and/or 5 ng ml −1 EGF (all from Peprotech) alone or in all possible pairwise combinations. For the 96-sample HMEC technical replicate experiment, in vitro cultures were prepared as described above, except all sorted wells contained both LEPs and MEPs. Cultures were then grown in complete M87A media for 72 h before isolation.
scRNA-seq sample preparation. For the proof-of-concept experiment, cells were first treated with trypsin for 5 min at 37 °C in 0.05% trypsin-EDTA before quenching with appropriate cell culture media. Single-cell suspensions were then pelleted for 4 min at 160 relative centrifugal force (rcf) and washed once with PBS before suspension in 90 μl of a 200 nM solution containing equimolar amounts of anchor LMO and sample barcode oligonucleotides in PBS. Anchor LMO-barcode labeling was performed for 5 min on ice before 10 μl of 2 μM co-anchor LMO in PBS (for a final concentration of 200 nM) was added to each cell pool. Following gentle mixing, the labeling reaction was continued on ice for another 5 min before cells were washed twice with PBS, resuspended in PBS with 0.04% BSA, filtered and pooled. The same workflow was also performed with CMOs. LMO-, CMO-and unlabeled control cells were then loaded into three distinct 10x microfluidics lanes.
For the original 96-plex HMEC experiment, LMO labeling was performed during trypsinization to minimize wash steps and thereby limit cell loss and preserve cell viability. HMECs cultured in 24-well plates were labeled for 5 min at 37 °C and 5% CO 2 in 190 μl of a 200 nM solution containing equimolar amounts of anchor LMO and sample barcode oligonucleotides in 0.05% trypsin-EDTA. Then, 10 μl of 4 μM co-anchor LMO in 0.05% trypsin-EDTA was then added to each well (for a final concentration of 200 nM) and labeling/trypsinization was continued for another 5 min at 37 °C and 5% CO 2 before quenching with appropriate cell culture media. A similar labeling protocol was used for the technical replicate experiment, except LMOs were incorporated once the cells were in single-cell suspension. Cells were then transferred to a 96-well plate for washing with 0.04% BSA in PBS. Finally, cells were pooled into a single aliquot, filtered through a 0.45-μm cell strainer and counted before loading 10x microfluidics lanes.
For the PDX experiment, primary tumors and lungs were cryopreserved after dissection from triple-negative breast cancer PDX models generated in NOD-SCID gamma mice as described previously 53 . The UCSF Institutional Animal Care and Use Committee (IACUC) reviewed and approved all animal experiments. On the day of the experiment, cryopreserved tissues were thawed and dissociated in digestion media containing 50 μg ml −1 Liberase TL (Sigma-Aldrich) and 2 × 10 4 U ml −1 DNase I (Sigma-Aldrich) in DMEM/F12 (Gibco) using standard GentleMacs protocols. Dissociated cells were then filtered through a 70-μm cell strainer to obtain a single-cell suspension before washing with PBS. Cells were then stained for 15 min on ice with 1:500 Zombie NIR (BioLegend, no. 423105) viability dye in PBS. Cells were then washed with 2% FBS in PBS before blocking for 5 min on ice with 100 μl 1:200 Fc-block (Tonbo, no. 70-0161-U500) in 2% FBS in PBS. After blocking, cells were stained for 45 min on ice with 100 μl of an antibody cocktail containing anti-mouse TER119 (FITC, Thermo Fisher, no. 11-5921-82), anti-mouse CD31 (FITC, Thermo Fisher, no. 11-0311-85), anti-mouse CD45 (BV450, Tonbo, no. 75-0451-U100), anti-mouse MHC-I (APC, eBioscience, no. 17-5999-82) and anti-human CD298 (PE, BioLegend, no. 341704). Cells were then washed with PBS before MULTI-seq labeling for 5 min on ice with 100 μl of 2.5 μM anchor LMO-barcode in PBS. Then, 20 μl of 15 μM co-anchor LMO in PBS was added to each cell pool (for a final concentration of 2.5 μM) and labeling was continued for another 5 min.
We used a ten fold greater LMO concentration for this experiment to account for increases in the total number of cells and lipophilic molecules remaining after dissociation. Following LMO labeling, cells were diluted with 100 μl of 2% FBS in PBS to 'quench' LMOs and washed once in 2% FBS in PBS. Finally, mCD45
+ mouse immune cells and hCD298 + human metastases from dissociated primary tumors and lungs were pooled after FACS enrichment, as described previously (Lawson et al. 53 , see Supplementary Fig. 8) . Cell pools were then processed on a single 10x microfluidics lane. HEK293 and MEF cells were cultured as described above. Nuclei were isolated from cells using a protocol adapted from 10x Genomics. Briefly, suspensions of HEK293, MEF or treated Jurkat cells were washed once with PBS, pelleted at 160 rcf (HEK293, MEF) or 300 rcf (Jurkat) for 4 min at 4 °C and suspended in chilled lysis buffer (0.5% Nonidet P40 Substitute, 10 mM Tris-HCl, 10 mM NaCl and 3 mM MgCl 2 in milliQ water) to a density of 2.5 × 10 6 cells ml . Lysis proceeded for 5 min on ice, after which the lysate was pelleted (500 rcf, 4 °C, 4 min) and washed three times in chilled resuspension buffer (2% BSA in PBS). Nuclei were then diluted to a concentration of ~10 6 nuclei ml −1 before LMO or CMO labeling. HEK293 and MEF cells were each divided into two samples and labeled with LMOs or CMOs (500 nM in resuspension buffer) using the same procedure as described for live cells (presence of BSA during labeling is the lone alteration as it is required to prevent nuclei clumping). Each Jurkat sample was labeled with LMOs, alone. Each sample was washed three times in 1 ml resuspension buffer (500 rcf, 4 °C, 4 min). The four LMO-and CMO-labeled HEK293 and MEF samples were pooled in equal portions and, separately, Jurkat samples were pooled in equal proportions. These final two samples were combined in a 1:1 ratio and processed on a single 10x microfluidics lane.
scRNA-seq and snRNA-seq library preparation. Sequencing libraries were prepared using a custom protocol based on the 10x Genomics Single Cell V2 and CITE-seq 52 workflows. Briefly, the 10x workflow was followed up until complementary DNA amplification, where 1 μl of 2.5 μM MULTI-seq additive primer was added to the cDNA amplification master mix:
MULTI-seq additive primer: 5′-CCTTGGCACCCGAGAATTCC-3′ This primer increases barcode sequencing yield by enabling the amplification of barcodes that successfully primed reverse transcription on mRNA capture beads but were not extended via template switching (Supplementary Fig. 9c ). The MULTI-seq additive primer was erroneously excluded during the proof-of-concept snRNA-seq library preparation and nuclei were still able to be robustly classified. Following amplification, barcode and endogenous cDNA fractions were separated using a 0.6× solid phase reversible immobilization (SPRI) size selection. The endogenous cDNA fraction was then processed according to the 10x workflow until NGS with the formats shown in Supplementary Table 7 .
To prepare the barcode fraction for NGS, contaminating oligonucleotides remaining from cDNA amplification were first removed using an established small RNA enrichment protocol (Beckman Coulter). Specifically, we increased the final SPRI ratio in the barcode fraction to 3.2× reaction volumes and added 1.8× reaction volumes of 100% isopropanol (Sigma-Aldrich). Beads were then washed twice with 400 μl of 80% ethanol and allowed to air dry for 2-3 min before elution with 50 μl of Buffer EB (Qiagen). Eluted barcode cDNA was then quantified using QuBit before library preparation PCR (95 °C, 5′; 98 °C, 15′; 60 °C, 30′; 72 °C, 30′; eight cycles; 72 °C, 1′; 4 °C hold). Each reaction volume was a total of 50 μl containing 26.25 μl 2× KAPA HiFi HotStart master mix (Roche), 2.5 μl of 10 μM TruSeq RPIX primer (Illumina), 2.5 μl of 10 μM TruSeq Universal Adapter primer (Illumina), 3.5 ng barcode cDNA and nuclease-free water.
TruSeq RPIX: 5 ′-CA AG CA GA AG AC GG CA TA CG AG AT N NN NN N GT GA CT GG AG TT-CCTTGGCACCCGAGAATTCCA-3′ TruSeq P5 adaptor: 5′-AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACG CTCTTCCGATCT-3′
Following library preparation PCR, remaining sequencing primers and contaminating oligonucleotides were removed via a 1.6× SPRI clean-up. Representative Bioanalyzer traces at different stages of the MULTI-seq library preparation workflow are documented in Supplementary Fig. 9 . Barcode libraries were sequenced using the NGS formats documented in Supplementary Table 2 . Sequencing reads predominantly aligned to the barcode reference sequences and resulted in high SNRs with low rates of duplicated UMIs, suggesting that barcode libraries were not sequenced to saturation for any of the presented experiments.
Design and synthesis of LMOs, CMOs and sample barcode oligonucleotides. Anchor and co-anchor LMO and CMO designs were adapted from Weber et al. 24 . Briefly, the anchor LMO has a 5′ lignoceric acid modification with two oligonucleotide domains. The 5′ end is complementary to the co-anchor LMO, which bears a 3′ palmitic acid, and the 3′ end is complementary to the PCR handle of the sample barcode oligonucleotide. The sample barcode was designed to have three components (as in Stoeckius et al. 52 ): (1) a 5′ PCR handle for barcode amplification and library preparation, (2) an 8-bp barcode with Hamming distance greater than three relative to all other utilized barcodes and (3) a 30-bp poly-A tail necessary for hybridization to the oligo-dT region of mRNA capture bead oligonucleotides. Identically designed anchor and co-anchor CMOs are conjugated to cholesterol at the 3′ or 5′ ends via a triethylene glycol (TEG) linker and are commercially available from Integrated DNA Technologies.
Anchor: {LA/Chol-TEG}-5′-GTAACGATCCAGCTGTCACTTGGAATTCTC GGGTGCCAAGG-3′
Co-anchor: 5′-AGTGACAGCTGGATCGTTAC-3′-{PA/TEG-Chol} Sample barcode: 5′-CCTTGGCACCCGAGAATTCCANNNNNNNNA 30 -3′
Computational methods. Expression library pre-processing. Expression library FASTQs were pre-processed using Cell Ranger (10x Genomics) and aligned to the hg19 (proof-of-concept scRNA-seq, HMEC), concatenated mm10-hg19 (PDX) or concatenated mm10-hg19 pre-mRNA (proof-of-concept snRNA-seq) reference transcriptomes. When multiple 10x lanes were sequenced in an experiment, Cell Ranger aggregate was used to perform read-depth normalization.
Cell/nuclei calling. For the proof-of-concept scRNA-seq, snRNA-seq and HMEC technical replicate experiments, cell-associated barcodes were defined using Cell Ranger. For the original 96-plex HMEC experiment, cells were defined as cell barcodes (1) associated with ≥600 total RNA UMIs that (2) were successfully classified during MULTI-seq sample classification workflow. We manually selected 600 RNA UMIs as a threshold to exclude low-quality cell barcodes. For the PDX experiment, we defined cells as barcodes (1) associated with ≥100 total RNA UMIs that (2) were successfully classified during the MULTI-seq sample classification workflow (Supplementary Materials).
Expression library analysis. Following pre-processing and cell/nuclei calling, RNA UMI count matrices were prepared for analysis using the 'Seurat' R package, as described previously 54, 55 . Briefly, genes expressed in fewer than three cells were discarded before the percentage of reads mapping to mitochondrial genes (%Mito) was computed for each cell. Outlier cells with elevated %Mito were visually defined and discarded. Data were then log 2 transformed, centered and scaled before variance due to %Mito and the total number of RNA UMIs were regressed out. Highly variable genes were then defined for each dataset by selecting mean expression and dispersion thresholds resulting in ~2,000 total genes. These variable genes were then used during principal component analysis and statistically significant principal components were defined by principal component elbow plot inflection point estimation. Significant principal components were then used for unsupervised Louvian clustering and dimensionality reduction with t-SNE 56 . Following pre-processing, differential gene expression analysis was conducted using the 'FindMarkers' command in 'Seurat' , with 'test.use' set to 'bimod' 57 and log fold-change thresholds set in a context-dependent fashion (Supplementary Materials). Other dataset-specific analyses are discussed in the Supplementary Materials. Dataset-specific 'Seurat' pre-processing parameters are given in Supplementary Table 8 .
Barcode library pre-processing. Raw barcode library FASTQs were converted to barcode UMI count matrices using custom scripts leveraging the 'ShortRead' 58 and 'stringdist' 59 R packages ( Supplementary Fig. 3 ). Briefly, raw FASTQs were first parsed to discard reads where the first 16 bases of R1 did not perfectly match any of the cell barcodes associated a pre-defined list of cell barcodes. Second, reads where the first eight bases of R2 did not align with <1 mismatch to any reference barcode were discarded. Third, reads were binned by cell barcodes and duplicated UMIs were identified as reads where bases 17-26 of R2 exactly matched. Finally, reference barcode alignment results were then parsed to remove duplicated UMIs before being converted into a final barcode UMI count matrix.
Barcode library sequencing statistics. MULTI-seq barcode library sequencing statistics were computed for classified singlets in all datasets presented in this study. SNR was computed for every cell by finding the quotient of the top two most abundant barcodes. Mean SNRs among all singlets for each dataset presented in this study are documented in Supplementary Table 2. The alignment rate was defined as the proportion of singlet-associated sequencing reads where the first eight bases of R2 aligned with <1 mismatch to any reference barcode.
MULTI-seq sample classification. MULTI-seq barcode UMI count matrices were used to classify cells into sample groups via a workflow inspired by previous scRNA-seq multiplexing approaches 15, 16, 21 (Supplementary Fig. 3 ). First, raw barcode reads were log 2 -transformed and mean-centered. The presence of each barcode was then visually inspected by performing t-SNE on the normalized barcode count matrix, as implemented in the 'Rtsne' R package with 'initial_dims' set to the total number of barcodes 56 . Missing barcodes (observed only for the 96-plex HMEC experiment) were discerned as those lacking any enrichment in barcode space and were removed.
Next, the top and bottom 0.1% of values for each barcode were excluded and the probability density function (PDF) for each barcode was defined by applying the 'approxfun' R function to Gaussian kernel density estimations produced using the 'bkde' function from the 'KernSmooth' R package 60 . We then sought to classify cells according to the assumption that groups of cells that are positive and negative for each barcode should manifest as local PDF maxima 15, 16 . To this end, we computed all local maxima for each PDF and defined negative and positive maxima as the most frequent and highest local maxima, respectively. This strategy assumes that truly barcoded cells will have the highest abundance for any given barcode and that no individual sample group will have more members than the sum of all other groups.
With these positive and negative approximations in hand, we next sought to define barcode-specific UMI thresholds. To find the best inter-maxima quantile for threshold definition (for example, an inter-maxima quantile of 0.5 corresponds to the mid-point), we iterated across 0.02-quantile increments and chose the value that maximized the number of singlet classifications. Sample classifications were then made using these barcode-specific UMI thresholds by discerning which thresholds each cell surpasses, with doublets being defined as cells surpassing >1 threshold 21 . Negative cells (that is, cells surpassing zero thresholds) were then removed and this procedure was repeated until all cells were classified as singlets or doublets. Subsets of negative cells could then be reclassified using semi-supervised learning 21 , where singlets defined during the initial workflow are used to initialize cluster centers during k-means clustering of negative cells (Supplementary Materials).
Statistical tests. Statistically significant TGFBI expression enrichment among TGF-β-stimulated and unstimulated HMECs in the proof-of-concept scRNA-seq experiment was assessed using the Wilcoxon rank-sum test (two-sided, n = 1,950 cells). Statistically significant TGFBI expression enrichment among LEPs and MEPs grouped according to signaling molecule exposure was assessed using the Wilcoxon rank-sum test (two-sided, n = 32 signaling molecule condition groups). Differentially expressed genes between clusters in all datasets were defined using the likelihood-ratio test for single-cell gene expression 57 with Bonferroni multiple comparisons adjustment. Statistically significant changes in lung immune cell-type proportions during metastatic progression were assessed using the two-proportion z-test with Bonferroni multiple comparisons adjustment (n = 44 tumor-stage/cell type groups).
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
Raw gene expression and barcode count matrices were uploaded to the Gene Expression Omnibus (GSE129578) along with pertinent metadata.
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R implementations of the MULTI-seq sample classification and barcode preprocessing pipelines are available in the 'deMULTIplex' R package, and can be downloaded at https://github.com/chris-mcginnis-ucsf/MULTI-seq. 
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